1 |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin,2021, 71(3): 209-249.
|
2 |
JONASCH E, ATKINS M B, CHOWDHURY S, et al. Combination of anti-angiogenics and checkpoint inhibitors for renal cell ccarcinoma: is the whole greater than the sum of its parts? [J]. Cancers (Basel), 2022, 14(3): 644.
|
3 |
程海波,吴勉华.周仲瑛教授“癌毒”学术思想探析[J].中华中医药杂志,2010,25(6):866-869.
|
4 |
PAGET S. The distribution of secondary growths in cancer of the breast [J]. The Lancet, 1889, 133(3421): 571-573.
|
5 |
CHEN Q, ZHANG M, HUANG H, et al. Single atom-doped nanosonosensitizers for mutually optimized sono/chemo-nanodynamic therapy of triple negative breast cancer [J]. Adv Sci (Weinh), 2023, 10(6): e2206244.
|
6 |
蒲雨康,黄玉琴,李伟 等.基于生物学信息探讨KIF26B在上皮性卵巢癌中的表达及临床意义[J].实用医学杂志,2022,38(23):2919-2926.
|
7 |
唐幸林子,王志宇,王能.基于癌毒病机理论探讨外泌体对肿瘤及肿瘤微环境的交互作用[J].中华中医药杂志,2021,36(11):6770-6774.
|
8 |
KHATAMI M. ‘Yin and Yang’ in inflammation: duality in innate immune cell function and tumorigenesis [J]. Expert Opin Biol Ther, 2008, 8(10): 1461-1472.
|
9 |
潘磊,夏孟蛟,李蒙丽,等.营卫不和与肿瘤的发生发展[J].中华中医药杂志,2019,34(1):47-49.
|
10 |
于鹏龙,张宏方,于东波,等. 试论肿瘤微环境对中医“癌毒”学说的认知意义[J]. 现代中医药,2016,36(1):47-49.
|
11 |
郭建辉. 周仲瑛教授“癌毒学说”新论[J]. 湖南中医药大学学报,2010,30(11):6-8.
|
12 |
黄帝内经素问[M]. 北京:人民卫生出版社,2012:53,95,391.
|
13 |
余听鸿. 外证医案汇编[M]. 上海:上海科学技术出版社,2010:162.
|
14 |
王冰冰,高永翔. 免疫学理论与中医学理论的相关性[J]. 四川中医,2015,33(2):34-36.
|
15 |
刘莹莹,张国尊,梁育飞,等. 益脾养肝法联合TACE对原发性肝癌患者肝功能及巨噬细胞介导细胞因子水平的影响[J]. 湖北中医药大学学报,2022,24(5):39-42.
|
16 |
王梅,武英茹,王越欣,等. 不同米炒党参对脾虚大鼠胃肠道功能、免疫功能、水液代谢的影响[J]. 中药材,2021,44(11):2566-2570.
|
17 |
CAO S, HUNG Y W, WANG Y C, et al. Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors [J]. Theranostics, 2022, 12(13): 6038-6056.
|
18 |
HASSAN G, OHARA T, AFIFY S M, et al. Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways [J]. J Exp Clin Cancer Res, 2022, 41(1): 29.
|
19 |
SCHNEIDER K M, MOHS A, GUI W, et al. Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment [J]. Nat Commun, 2022, 13(1): 3964.
|
20 |
MEDZHITOV R. Origin and physiological roles of inflammation [J]. Nature, 2008, 454(7203): 428-435.
|
21 |
梁桂林,罗毅,王彬,等. 固本宣肺汤治疗稳定期慢性阻塞性肺疾病疗效及对免疫功能的影响[J]. 中华中医药学刊,2020,38(8): 183-186.
|